/주식/TBPH
TBPH

TBPH

USD

Theravance Biopharma Inc. Ordinary Shares

$10.610-0.170 (-1.577%)

실시간 가격

Healthcare
생명공학
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$10.780

고가

$10.780

저가

$10.520

거래량

0.00M

기업 기본 정보

시가총액

530.5M

산업

생명공학

국가

United States

거래 통계

평균 거래량

0.28M

거래소

NGM

통화

USD

52주 범위

저가 $7.44현재가 $10.610고가 $11.82

관련 뉴스

PR Newswire

Theravance Biopharma Announces Ampreloxetine Presentations at the International MSA Congress

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced presentation of analyses of its previous Phase 3...

더 보기
Theravance Biopharma Announces Ampreloxetine Presentations at the International MSA Congress
PR Newswire

Theravance Biopharma, Inc. Reports First Quarter 2025 Financial Results and Provides Corporate Update

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial and operational results for the first...

더 보기
Theravance Biopharma, Inc. Reports First Quarter 2025 Financial Results and Provides Corporate Update
PR Newswire

Theravance to Present Analyses of Ampreloxetine and Neurogenic Orthostatic Hypotension at the 2025 International MSA Congress

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced that analyses of the initial Phase 3 program of...

더 보기
Theravance to Present Analyses of Ampreloxetine and Neurogenic Orthostatic Hypotension at the 2025 International MSA Congress
PR Newswire

Theravance Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025

Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its first quarter 2025 financial results and provide a business update after market close on...

더 보기
Theravance Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025